NCT02583958

Assessment of Efficacy & Safety for a New Wound Dressing Urgo 310 3166 in the Local Treatment of VLU or Mixed Leg Ulcers

Assessment of Efficacy and Safety for a New Wound Dressing URGO 310 3166 in the Local Treatment of Venous or Mixed Leg Ulcers: A European, Randomised Clinical Trial

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: —
• Sponsor: Laboratoires URGO · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Assessment of efficacy and safety for a new wound dressing URGO 310 3166 in the local treatment of venous or mixed leg ulcers: a European, randomised clinical trial.

Conditions

• Leg Ulcers

Interventions

Type	Name	Description
DEVICE	Urgo 3103166	URGO 310 3166 dressing should be changed as often as required (let to the Investigator's convenience). The dressing change frequency is based on the exudate level and the clinical progress of the wound (up to 7 days).
DEVICE	Aquacel Extra	Aquacel Extra hydrofibre dressing can be left in place up to 7 days, where clinically indicated.

Timeline

• Start date: 2014-10-01
• Primary completion: 2017-01-01
• Completion: 2017-06-01
• First posted: 2015-10-22
• Last updated: 2015-10-22

Locations

1 site across 1 country: France